Health Blueprint

Back to Longevity News

News summary

Continuous Glucose Monitoring Across the Entire Management Spectrum of Insulinoma: From Screening and Diagnosis to Perioperative Evaluation and Long-Term Follow-Up

Source: Frontiers - Health • Published: 02 Nov 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

Review finds CGM uncovers large, often asymptomatic hypoglycemia in insulinoma patients.

Continuous Glucose Monitoring Across the Entire Management Spectrum of Insulinoma: From Screening and Diagnosis to Perioperative Evaluation and Long-Term Follow-Up
Key Takeaways
  • CGM often uncovers asymptomatic hypoglycemia missed by finger-sticks.
  • CGM metrics are useful for outpatient triage and diagnostic evaluation.
  • CGM benefits were not shown to improve hard clinical outcomes.
Read the full article at Frontiers - Health ↗

Continue exploring

Recommended MoL Picks

MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.MoL PickSeed Oils and Health: Inflammation, Processing and EvidenceHuman trials, processing risks and long-term health ask different questions. What can seed-oil research tell us—and what remains unresolved?MoL PickCan Exergaming Improve Balance? What Older Adults Should KnowMotion-controlled games may make balance practice easier to repeat. The evidence supports a structured adjunct—not a fall-proofing shortcut.